Go to content
UR Home

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

URN to cite this document:
DOI to cite this document:
Bredthauer, Andre ; Kopfmueller, Manuel ; Gruber, Michael ; Pfaehler, Sophie-Marie ; Lehle, Karla ; Petermichl, Walter ; Seyfried, Timo ; Bitzinger, Diane I. ; Redel, Andreas
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 12 May 2020 11:52


Introduction. Anticoagulants such as argatroban and heparins (low-molecular-weight and unfractionated) play an immense role in preventing thromboembolic complications in clinical practice. Nevertheless, they can also have a negative effect on the immune system. This study is aimed at investigating the influence of these substances on polymorphonuclear neutrophils (PMNs), whose nonspecific defense ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons